These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29046030)

  • 1. [Immunopathology of chronic obstructive pulmonary disease].
    Martínez-Aguilar NE; Vargas-Camaño ME; Hernández-Pliego RR; Chaia-Semerena GM; Pérez-Chavira MR
    Rev Alerg Mex; 2017; 64(3):327-346. PubMed ID: 29046030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel aspects of pathogenesis and regeneration mechanisms in COPD.
    Bagdonas E; Raudoniute J; Bruzauskaite I; Aldonyte R
    Int J Chron Obstruct Pulmon Dis; 2015; 10():995-1013. PubMed ID: 26082624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic obstructive pulmonary disease and comorbidity: a review and consideration of pathophysiology.
    Tan SL; Wood AM
    Panminerva Med; 2009 Jun; 51(2):81-93. PubMed ID: 19776710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cell senescence and pathophysiology of chronic lung diseases: role in chronic obstructive pulmonary disease].
    Adnot S
    Bull Acad Natl Med; 2014; 198(4-5):659-71. PubMed ID: 26753399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chronic obstructive pulmonary disease comorbidity spectrum in Japan differs from that in western countries.
    Takahashi S; Betsuyaku T
    Respir Investig; 2015 Nov; 53(6):259-70. PubMed ID: 26521103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease.
    Hogg JC
    Lancet; 2004 Aug 21-27; 364(9435):709-21. PubMed ID: 15325838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary disease.
    Camiciottoli G; Bigazzi F; Magni C; Bonti V; Diciotti S; Bartolucci M; Mascalchi M; Pistolesi M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2229-2236. PubMed ID: 27695310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and burden of comorbidities in Chronic Obstructive Pulmonary Disease.
    Corlateanu A; Covantev S; Mathioudakis AG; Botnaru V; Siafakas N
    Respir Investig; 2016 Nov; 54(6):387-396. PubMed ID: 27886849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of chronic obstructive pulmonary disease.
    Tuder RM; Petrache I
    J Clin Invest; 2012 Aug; 122(8):2749-55. PubMed ID: 22850885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease.
    Foschino Barbaro MP; Carpagnano GE; Spanevello A; Cagnazzo MG; Barnes PJ
    Int J Immunopathol Pharmacol; 2007; 20(4):753-63. PubMed ID: 18179748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The objective evaluation of obstructive pulmonary diseases with spirometry.
    Ozkaya S; Dirican A; Tuna T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Chronic Obstructive Pulmonary Disease an Accelerated Aging Disease?
    MacNee W
    Ann Am Thorac Soc; 2016 Dec; 13 Suppl 5():S429-S437. PubMed ID: 28005421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD).
    Izquierdo-Alonso JL; Rodriguez-Gonzálezmoro JM; de Lucas-Ramos P; Unzueta I; Ribera X; Antón E; Martín A
    Respir Med; 2013 May; 107(5):724-31. PubMed ID: 23419828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Airway bacteria drive a progressive COPD-like phenotype in mice with polymeric immunoglobulin receptor deficiency.
    Richmond BW; Brucker RM; Han W; Du RH; Zhang Y; Cheng DS; Gleaves L; Abdolrasulnia R; Polosukhina D; Clark PE; Bordenstein SR; Blackwell TS; Polosukhin VV
    Nat Commun; 2016 Apr; 7():11240. PubMed ID: 27046438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspects on pathophysiological mechanisms in COPD.
    Larsson K
    J Intern Med; 2007 Sep; 262(3):311-40. PubMed ID: 17697154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COPD: a multifactorial systemic disease.
    Huertas A; Palange P
    Ther Adv Respir Dis; 2011 Jun; 5(3):217-24. PubMed ID: 21429981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canakinumab for the treatment of chronic obstructive pulmonary disease.
    Rogliani P; Calzetta L; Ora J; Matera MG
    Pulm Pharmacol Ther; 2015 Apr; 31():15-27. PubMed ID: 25660162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic obstructive pulmonary disease: linking outcomes and pathobiology of disease modification.
    Rennard SI
    Proc Am Thorac Soc; 2006 May; 3(3):276-80. PubMed ID: 16636098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease.
    McNicholas WT
    Am J Respir Crit Care Med; 2009 Oct; 180(8):692-700. PubMed ID: 19628778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic inflammation and comorbidities in chronic obstructive pulmonary disease.
    Agustí A; Faner R
    Proc Am Thorac Soc; 2012 May; 9(2):43-6. PubMed ID: 22550240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.